The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The Hemostats And Tissue Sealants Market Between 2026 And 2030?
The hemostats and tissue sealants market size has experienced significant growth in recent years. It is projected to expand from $4.35 billion in 2025 to $4.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.7%. Historically, this growth can be attributed to factors such as the reliance on traditional mechanical hemostats, the limited availability of synthetic sealants, an increase in surgical procedures, the development of hospital infrastructure, and the early adoption of fibrin-based sealants.
The hemostats and tissue sealants market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $5.97 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.5%. The predicted growth during this period stems from several factors, including the creation of advanced tissue adhesives, an increase in minimally invasive surgical procedures, the rising prevalence of cardiovascular and trauma surgeries, enhanced research efforts in hemostasis technologies, and the broadening of direct and online sales avenues. Key developments expected within this forecast timeframe encompass the increasing embrace of sophisticated hemostatic solutions, a surge in the application of synthetic and hybrid sealants, the continued expansion of cardiovascular and trauma operations, an emphasis on procedures that are minimally invasive and promote quicker recovery, and an uptick in research and academic endeavors related to hemostasis.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25781&type=smp
Which Drivers Are Supporting The Hemostats And Tissue Sealants Market Growth?
The rising number of surgical procedures is projected to propel the growth of the hemostats and tissue sealants market in the future. Surgical procedures are medical operations that involve manual and instrumental techniques performed by surgeons to diagnose, treat, or remove diseased tissues or organs, or to repair bodily functions. The increase in surgical procedures is attributed to the growing prevalence of chronic diseases, which often require surgical intervention for effective management, treatment, or complication prevention. Hemostats and tissue sealants assist surgical procedures by effectively controlling bleeding and sealing tissues, thereby reducing complications and improving surgical outcomes. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional body for board-certified aesthetic plastic surgeons, there was a 5.5% rise in surgical procedures in 2023, with more than 15.8 million surgeries and 19.1 million non-surgical procedures performed globally. Therefore, the rising number of surgical procedures is driving the growth of the hemostats and tissue sealants market.
What Segment Categories Shape The Hemostats And Tissue Sealants Market Segment Landscape?
The hemostats and tissue sealants market covered in this report is segmented –
1) By Product Type: Topical Hemostats, Adhesives And Tissue Sealants, Fibrin Sealants, Other Product Types
2) By Composition: Biological Based, Synthetic Based, Combination
3) By Distribution Channel: Direct Sales, Distributors, Online Sales
4) By Application: Surgical Procedures, Trauma Cases, Cardiovascular Surgery, General Surgery, Other Applications
5) By End-Users: Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, Research And Academic Institutes
Subsegments:
1) By Topical Hemostats: Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Combination Hemostats
2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives, Biological Tissue Adhesives, Cyanoacrylate-Based Adhesives
3) By Fibrin Sealants: Liquid Fibrin Sealants, Patch-Based Fibrin Sealants
4) By Other Product Types: Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats
Which Trends Are Expected To Impact The Hemostats And Tissue Sealants Market?
Leading firms within the hemostat and tissue sealants market are concentrating their efforts on creating sophisticated products, like immediate-use absorbable collagen pads hemostat, aimed at enhancing effectiveness and results in surgical procedures. These immediate-use absorbable collagen pads of hemostat contain bioactive, resorbable substances that allow for instant application, removing the need for prior preparation, thereby facilitating rapid and efficient sealing of tissue and dura, alongside achieving hemostasis. As an illustration, in April 2025, Baxter International Inc., a US-based healthcare firm, introduced the Hemopatch Sealing Hemostat, designed for room temperature storage, during a symposium held in Austria. The innovative room temperature Hemopatch sealing hemostat provides the advantage of being ready-to-use without requiring pre-warming, which allows for swift application during surgical operations. This product is an advanced absorbable pad that can be directly applied in both open and minimally invasive surgical settings, thereby removing any necessity for product preparation or refrigeration. Its robust adhesive qualities, prolonged shelf life, and fast hemostatic action assist surgeons in more effectively managing bleeding or leakage, ultimately contributing to enhanced surgical precision and patient recuperation across a diverse range of medical specialties.
Who Are The Companies Operating Across The Hemostats And Tissue Sealants Market Value Chain?
Major companies operating in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.
Get The Full Hemostats And Tissue Sealants Market Report:
https://www.thebusinessresearchcompany.com/report/hemostats-and-tissue-sealants-global-market-report
Which Region Is The Largest In The Hemostats And Tissue Sealants Market?
North America was the largest region in the hemostats and tissue sealants market in 2025. The regions covered in the hemostats and tissue sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Hemostats And Tissue Sealants Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=25781&type=smp
Browse Through More Reports Similar to the Global Hemostats And Tissue Sealants Market 2026, By The Business Research Company
Absorbable Hemostats Market Report 2026
https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report
Hemostasis Products Market Report 2026
https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report
Hemostasis Diagnostic Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model